- Home
- MMI vs IMCR Comparison
MMI vs IMCR Comparison
Compare MMI & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMI
- IMCR
- Stock Information
- Founded
- MMI 1971
- IMCR 2008
- Country
- MMI United States
- IMCR United Kingdom
- Employees
- MMI N/A
- IMCR N/A
- Industry
- MMI Real Estate
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMI Finance
- IMCR Health Care
- Exchange
- MMI Nasdaq
- IMCR Nasdaq
- Market Cap
- MMI 1.6B
- IMCR 1.7B
- IPO Year
- MMI 2013
- IMCR 2021
- Fundamental
- Price
- MMI $38.27
- IMCR $28.33
- Analyst Decision
- MMI Sell
- IMCR Buy
- Analyst Count
- MMI 1
- IMCR 13
- Target Price
- MMI $30.00
- IMCR $65.18
- AVG Volume (30 Days)
- MMI 99.0K
- IMCR 291.0K
- Earning Date
- MMI 02-14-2025
- IMCR 11-06-2024
- Dividend Yield
- MMI 1.32%
- IMCR N/A
- EPS Growth
- MMI N/A
- IMCR N/A
- EPS
- MMI N/A
- IMCR N/A
- Revenue
- MMI $622,225,000.00
- IMCR $296,312,000.00
- Revenue This Year
- MMI N/A
- IMCR $29.19
- Revenue Next Year
- MMI $26.79
- IMCR $12.56
- P/E Ratio
- MMI N/A
- IMCR N/A
- Revenue Growth
- MMI N/A
- IMCR 25.09
- 52 Week Low
- MMI $29.93
- IMCR $27.69
- 52 Week High
- MMI $44.24
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- MMI 32.66
- IMCR 31.28
- Support Level
- MMI $39.73
- IMCR $27.69
- Resistance Level
- MMI $40.71
- IMCR $29.91
- Average True Range (ATR)
- MMI 0.96
- IMCR 1.48
- MACD
- MMI -0.51
- IMCR -0.32
- Stochastic Oscillator
- MMI 12.52
- IMCR 11.45
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.